Searched for
CIPLA GLOBAL CFO
Cipla promoters to sell up to 2.53% for Rs 2,637 croreThe move, days after the company posted its best annual results, has triggered speculation that more such transactions could be in the offi...- Stocks in news: RIL, Jio Financial, JSW Infra, Cipla, Gujarat GasReliance Industries Ltd will announce its March quarter results on April 22. Along with the quarterly numbers, the company's board will als...
- Biocon Biologics names Kedar Upadhye as new CFOUpadhye will be replace current CFO MB Chinappa who will take up strategic finance role at Biocon Group and will work with Peter Bains, the...
- Demand for Covid drugs down, says Cipla Global CFOThe third wave has been fuelled by the Omicron variant, which is highly infectious yet milder, causing flu-like symptoms such as fever, bod...
- Pharma Inc battles new challenges as Covid-led tailwinds peter outAs the impact of the pandemic abates in the country, its impact on Indian pharma seems to be wearing off - both on the ground as well as bo...
- Cipla is undergoing a big transformation and is doing something it once eschewedA difficult transformation is underway at Cipla, one of India’s largest and oldest pharma companies.
- Avenue Therapeutics buy will allow Cipla to enter specialty hospital business in US: Kedar UpadhyeWe are happy with the acceleration of the US pipeline, says Cipla’s Global CFO.
- CFOs’ salary jumps over 40% with rising demand for financial skill setsCompensation packages are starting to match the growing challenges that the new-age CFO has to face, said Santrupt Misra, director, group h...
- In a double role: CFOs donning mantle of CEOLast month, NS Kannan, who served as a CFO at ICICI Bank, was appointed the CEO of ICICI Prudential Life Insurance Company.
- Cipla targets $1-billion revenues from domestic market in FY19The company reported revenues of Rs 15,219 crore, growing 6 per cent, with income from the India operations seeing a 6.3 per cent jump at R...
- Chief financial officers are taking over as CEOsToday, CFOs are the most sought-after candidates to occupy the corner room, thanks to changed business environment and an evolved role.
- US pathway for respiratory is going to be a little bit different: Kedar Upadhye of Cipla"We will operate in across the channels and yes we have a good partner and we believe we will get our fair share of the market."
- Pressure to meet targets and debt management challenges bring role of CFO under limelightCFOs are increasingly taking centre stage in boardrooms and the churn in their ranks in India Inc. has been the highest in 2016, with over ...
- Cipla appoints Kedar Upadhye as Global CFOUntil recently, Kedar was Vice President, Global Generics Finance and Head of Investor Relations in Dr Reddy's Laboratories, Cipla said in ...
- Meet India’s next generation of women leaders in pharmaThey are not afraid of taking business risks or foraying into newer businesses and have created environment and pushed for HR reforms targe...
- Cipla hires Kedar Upadhye from Dr. Reddy's as global CFOCipla said in a June 8 announcement to stock exchanges, Kedar Upadhye will be joining the organization as its Global chief financial office...
- Cipla reshuffles its senior management team againIndia’s third-largest drug maker Cipla has reshuffled its senior management team, the third time it’s doing so in as many years.
- Expect to deliver 21% margin for 2014-15: Rajesh Garg, CiplaOverall year is well intact & as we have looked our April & May performance, we will be able to get the full year 2014-2015 closer to what ...
- Don't look now, Cipla just might be changing, says Cipla chairman & MD Dr Yusuf HamiedET delves into why one of India's oldest and best-known pharma companies is taking a hard look at itself.
- Pharma brand launches in local market dipsNew brand launches in the local drug market have declined over the last few years as the number of original drugs going off patent has come...
Load More
